Review




Structured Review

Bangs Laboratories quantum simply cellular (qsc) anti-human igg kit
(c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the <t>QSC</t> anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.
Quantum Simply Cellular (Qsc) Anti Human Igg Kit, supplied by Bangs Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantum+simply+cellular+(qsc)+anti-human+igg+kit/quantum+simply+cellular+system/pmc10865928-272-23-30
Average 90 stars, based on 1 article reviews
quantum simply cellular (qsc) anti-human igg kit - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma"

Article Title: CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma

Journal: mAbs

doi: 10.1080/19420862.2024.2310248

(c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the QSC anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.
Figure Legend Snippet: (c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the QSC anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.

Techniques Used: Binding Assay, Inhibition, Recombinant, Expressing, Control, Standard Deviation

Related Articles

other:

Article Title: PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies
Article Snippet: Samples were washed with buffer and assayed on a FACS machine (BD FACSCanto II) in conjunction with a microsphere bead set (Quantum Simply Cellular anti-Human IgG kit; Bangs Labs catalog No. 816B) to determine the specific antibody binding capacity of each antibody.

Article Title: CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma
Article Snippet: The surface expression of CD47 and CD20 on NHL cell lines was determined prior to the assessment of SIRPα binding competition using the Quantum Simply Cellular (QSC) anti-human IgG kit (Bangs Laboratories), as per the manufacturer’s instructions.

Article Title: Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors
Article Snippet: Purpose: c-KIT overexpression is well-recognized in cancers such as GIST, SCLC, melanoma, NSCLC and AML.. Treatment with the small molecule inhibitors imatinib, sunitinib and regorafenib result in resistance (c-KIT mutant tumors) or limited activity (c-KIT wildtype tumors).. We selected an anti-c-KIT ADC approach to evaluate the anti-cancer activity in multiple disease models.

Article Title: 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model
Article Snippet: Fluorescence quantitation was performed using the Quantum Simply Cellular (QSC) anti-Human IgG Kit (Bangs Laboratories, Inc) to determine the antibody-binding capacity (ABC) of human CD20expressing cells.

Article Title: HLA-restricted, peptide-specific antigen binding proteins
Article Snippet: For quantitation, the QUANTUM SIMPLY CELLULAR anti-Human IgG kit was used (Bangs Laboratories) along with the technical assistance of Hong-fen Guo in our laboratory.

Article Title: RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models
Article Snippet: Receptor density on cell lines was determined using Quantum Simply Cellular (QSC) anti-human IgG kit (Bangs Laboratories) according to manufacturer’s protocol.

Fluorescence:

Article Title: 89 Zr-ImmunoPET shows therapeutic efficacy of anti-CD20 interferon-α fusion protein in a murine B-cell lymphoma model
Article Snippet: .. Fluorescence quantitation was performed using the Quantum Simply Cellular (QSC) anti-Human IgG Kit (Bangs Laboratories, Inc) to determine the antibody binding capacity (ABC) of human CD20 expressing cells. ..

Quantitation Assay:

Article Title: 89 Zr-ImmunoPET shows therapeutic efficacy of anti-CD20 interferon-α fusion protein in a murine B-cell lymphoma model
Article Snippet: .. Fluorescence quantitation was performed using the Quantum Simply Cellular (QSC) anti-Human IgG Kit (Bangs Laboratories, Inc) to determine the antibody binding capacity (ABC) of human CD20 expressing cells. ..

Binding Assay:

Article Title: 89 Zr-ImmunoPET shows therapeutic efficacy of anti-CD20 interferon-α fusion protein in a murine B-cell lymphoma model
Article Snippet: .. Fluorescence quantitation was performed using the Quantum Simply Cellular (QSC) anti-Human IgG Kit (Bangs Laboratories, Inc) to determine the antibody binding capacity (ABC) of human CD20 expressing cells. ..

Expressing:

Article Title: 89 Zr-ImmunoPET shows therapeutic efficacy of anti-CD20 interferon-α fusion protein in a murine B-cell lymphoma model
Article Snippet: .. Fluorescence quantitation was performed using the Quantum Simply Cellular (QSC) anti-Human IgG Kit (Bangs Laboratories, Inc) to determine the antibody binding capacity (ABC) of human CD20 expressing cells. ..



Similar Products

90
Bangs Laboratories quantum simply cellular (qsc) anti-human igg kit
(c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the <t>QSC</t> anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.
Quantum Simply Cellular (Qsc) Anti Human Igg Kit, supplied by Bangs Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantum+simply+cellular+(qsc)+anti-human+igg+kit/quantum+simply+cellular+system/pmc10865928-272-23-30
Average 90 stars, based on 1 article reviews
quantum simply cellular (qsc) anti-human igg kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Bangs Laboratories quantum simply cellular qsc anti human igg kit
(c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the <t>QSC</t> anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.
Quantum Simply Cellular Qsc Anti Human Igg Kit, supplied by Bangs Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantum+simply+cellular+(qsc)+anti-human+igg+kit/anti+cellular+igg1+kit+mouse+quantum+simply/pmc08983440-30-6-13
Average 86 stars, based on 1 article reviews
quantum simply cellular qsc anti human igg kit - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


(c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the QSC anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.

Journal: mAbs

Article Title: CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma

doi: 10.1080/19420862.2024.2310248

Figure Lengend Snippet: (c) Screening strategy for an optimally detuned anti-CD47 fab. A library of detuned CD47×EGFR bispecifics were screened for minimal binding to non-target CD47 + EGFR − Raji cells and maximum inhibition of SIRPα binding to CD47 + EGFR + FaDu cells. (d) Top: Representative curves of recombinant SIRPα binding to CD47 on the surface of each lymphoma cell line evaluated in the presence of CC-96673. Bottom: a summary of IC50 values and maximum percent inhibition of recombinant SIRPα binding to cell surface CD47 by CC-96673. The surface expression of CD47 and CD20 on NHL cell lines was determined using the QSC anti-human IgG kit and antibody-binding capacity (ABC) values were calculated automatically using the QuickCal template. Each symbol represents mean percent of control of SIRPα binding with error bars depicting standard deviation (SD) of two independent experiments.

Article Snippet: The surface expression of CD47 and CD20 on NHL cell lines was determined prior to the assessment of SIRPα binding competition using the Quantum Simply Cellular (QSC) anti-human IgG kit (Bangs Laboratories), as per the manufacturer’s instructions.

Techniques: Binding Assay, Inhibition, Recombinant, Expressing, Control, Standard Deviation